ChIP-seq is one of the core experimental resources available to understand genome-wide epigenetic interactions and identify the functional elements associated with diseases. The analysis of ChIP-seq data is important but poses a difficult computational challenge, due to the presence of irregular noise and bias on various levels. Although many peak-calling methods have been developed, the current computational tools still require, in some cases, human manual inspection using data visualization. However, the huge volumes of ChIP-seq data make it almost impossible for human researchers to manually uncover all the peaks. Recently developed convolutional neural networks (CNN), which are capable of achieving human-like classification accuracy, can be applied to this challenging problem. In this study, we design a novel supervised learning approach for identifying ChIP-seq peaks using CNNs, and integrate it into a software pipeline called CNN-Peaks. We use data labeled by human researchers who annotate the presence or absence of peaks in some genomic segments, as training data for our model. The trained model is then applied to predict peaks in previously unseen genomic segments from multiple ChIP-seq datasets including benchmark datasets commonly used for validation of peak calling methods. We observe a performance superior to that of previous methods.
The Evidential regression network (ENet) estimates a continuous target and its predictive uncertainty without costly Bayesian model averaging. However, it is possible that the target is inaccurately predicted due to the gradient shrinkage problem of the original loss function of the ENet, the negative log marginal likelihood (NLL) loss. In this paper, the objective is to improve the prediction accuracy of the ENet while maintaining its efficient uncertainty estimation by resolving the gradient shrinkage problem. A multi-task learning (MTL) framework, referred to as MT-ENet, is proposed to accomplish this aim. In the MTL, we define the Lipschitz modified mean squared error (MSE) loss function as another loss and add it to the existing NLL loss. The Lipschitz modified MSE loss is designed to mitigate the gradient conflict with the NLL loss by dynamically adjusting its Lipschitz constant. By doing so, the Lipschitz MSE loss does not disturb the uncertainty estimation of the NLL loss. The MT-ENet enhances the predictive accuracy of the ENet without losing uncertainty estimation capability on the synthetic dataset and real-world benchmarks, including drug-target affinity (DTA) regression. Furthermore, the MT-ENet shows remarkable calibration and out-of-distribution detection capability on the DTA benchmarks.
The Evidential regression network (ENet) estimates a continuous target and its predictive uncertainty without costly Bayesian model averaging. However, it is possible that the target is inaccurately predicted due to the gradient shrinkage problem of the original loss function of the ENet, the negative log marginal likelihood (NLL) loss. In this paper, the objective is to improve the prediction accuracy of the ENet while maintaining its efficient uncertainty estimation by resolving the gradient shrinkage problem. A multi-task learning (MTL) framework, referred to as MT-ENet, is proposed to accomplish this aim. In the MTL, we define the Lipschitz modified mean squared error (MSE) loss function as another loss and add it to the existing NLL loss. The Lipschitz modified MSE loss is designed to mitigate the gradient conflict with the NLL loss by dynamically adjusting its Lipschitz constant. By doing so, the Lipschitz MSE loss does not disturb the uncertainty estimation of the NLL loss. The MT-ENet enhances the predictive accuracy of the ENet without losing uncertainty estimation capability on the synthetic dataset and real-world benchmarks, including drug-target affinity (DTA) regression. Furthermore, the MT-ENet shows remarkable calibration and out-of-distribution detection capability on the DTA benchmarks.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.